Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

(NasdaqGM:AVDL), – Expands Avadel's pipeline with salt-free, artificial sweetener-free, once-at-bedtime oxybate for treatment of narcolepsy and idiopathic hypersomnia – – Initial pharmacokinetic (PK) and comparative bioavailability study to initiate in fourth quarter 2025 with pivotal PK trial planned for second half 2026 – – XWPharma to receive $20 million upfront; potential for development, regulatory and […]

Actelis Networks to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference

(NASDAQ:ASNS), FREMONT, Calif, Sept. 03, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that its senior management will deliver a presentation and be available for one-on-one meetings with investors, at the upcoming 27th Annual

Americold Realty Trust, Inc. Declares Third Quarter 2025 Dividend

(NYSE:COLD), ATLANTA, GA., Sept. 03, 2025 (GLOBE NEWSWIRE) — Americold Realty Trust (NYSE: COLD), a global leader in temperature-controlled logistics, real estate, and value-added services focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, today announced that its Board of Directors has declared a dividend of $0.23 per share for the third quarter

New Meta-Analysis Demonstrates that Access to the GeneSight Test Can Significantly Improve Response and Remission Rates for Patients with Depression

(NASDAQ:MYGN), SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta-analysis of six prospective controlled studies1 that included 3,532 adults with major depressive disorder (MDD). The meta-analysis showed that when GeneSight(R) Psychotropic test results

BUUU Group Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option

(NASDAQ:BUUU), Hong Kong, Sept. 03, 2025 (GLOBE NEWSWIRE) — BUUU Group Limited (Nasdaq: BUUU) (the “Company”), an established meetings, incentives, conferences and exhibitions (“MICE”) solutions provider based in Hong Kong , today announced the partial exercise of the over-allotment option (the “Over-Allotment”) by the underwriter (the “Underwriter”) of its initial public offering (the “Offering”) to

WillScot Announces Leadership Transition

(NASDAQ:WSC), President and COO Tim Boswell to Succeed Brad Soultz as Chief Executive Officer Worthing Jackman, Chairman of the Board, Named Executive Chairman of the Board Jeff Sagansky Appointed Lead Independent Director PHOENIX, Sept. 03, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions,

Pennant Announces Home Health Acquisition in Wyoming

(NASDAQ:PNTG), EAGLE, Idaho, Sept. 03, 2025 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective September 1, 2025, it has acquired a premier home health agency and outpatient therapy operation in Wyoming. Both

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:OLMA), SAN FRANCISCO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to four new employees to purchase an aggregate of 124,000

Atico Announces Completion of The Environmental Consultation Process at La Plata Project

(TSX-V:ATY),(OTC US:ATCMF),(Other OTC:ATCMF), VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTCQX: ATCMF) is pleased to announce that the Ministry of the Environment, Water, and Ecological Transition (MAATE) successfully concluded the Community Participation Process for Environmental Consultation (PPC) as a final step in the

Japan Smaller Capitalization Fund, Inc. Announces Annual Meeting of Shareholders

(NYSE:JOF), NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) (the “Fund”) announced that it will hold its annual meeting of shareholders (the “Meeting”) at the offices of Nomura Asset Management U.S.A., Inc., 309 West 49th Street, New York, N.Y. 11980, at 10:30 a.m., Eastern Time on November 13,

Scroll to Top